Lactoferrin delivery systems: approaches for its more effective use

Bibliography

• Masson PL, Heremans JF, Schonne E. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med 1969;130(3):643-58
   PubMed Web of Science ®Google Scholar
• Bullen JJ, Rogers HJ, Leigh L. Iron-binding proteins in milk and resistance to Escherichia coli infection in infants. Br Med J 1972;1(5792):69-75
   PubMed Web of Science ®Google Scholar
• Weinberg ED. The therapeutic potential of lactoferrin. Expert Opin Investig Drugs 2003;12(5):841-51
   PubMed Web of Science ®Google Scholar
• Ward PP, Paz E, Conneely OM. Multifunctional roles of lactoferrin: a critical overview. Cell Mol Life Sci 2005;62(22):2540-8
   PubMed Web of Science ®Google Scholar
• Yamauchi K. Lactoferrin. J Jpn Soc Food Sci Technol 2006;53(3):193
   Google Scholar
• Yamauchi K, Toida T, Nishimura S, 13-Week oral repeated administration toxicity study of bovine lactoferrin in rats. Food Chem Toxicol 2000;38(6):503-12
   PubMed Web of Science ®Google Scholar
• Hayes TG, Falchook GF, Varadhachary GR, Phase I trial of oral talactoferrin alfa in refractory solid tumors. Invest New Drugs 2006;24(3):233-40
   PubMed Web of Science ®Google Scholar
• Prenner ML, Prgomet C, Sauerwein H, Effects of lactoferrin feeding on growth, feed intake and health of calves. Arch Anim Nutr 2007;61(1):20-30
   PubMed Web of Science ®Google Scholar
• Mulder AM, Connellan PA, Oliver CJ, Bovine lactoferrin supplementation supports immune and antioxidant status in healthy human males. Nutr Res 2008;28(9):583-9
   PubMed Web of Science ®Google Scholar
• Arnold RR, Brewer M, Gauthier JJ. Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect Immun 1980;28(3):893-8
   PubMed Web of Science ®Google Scholar
• Lee NY, Kawai K, Nakamura I, Susceptibilities against bovine lactoferrin with microorganisms isolated from mastitic milk. J Vet Med Sci 2004;66(10):1267-9
   PubMed Web of Science ®Google Scholar
• Orsi N. The antimicrobial activity of lactoferrin: current status and perspectives. Biometals 2004;17(3):189-96
   PubMed Web of Science ®Google Scholar
• Weinberg ED. Iron and susceptibility to infectious disease. Science 1974;184(140):952-6
   PubMed Web of Science ®Google Scholar
• Arnold RR, Cole MF, McGhee JR. A bactericidal effect for human lactoferrin. Science 1977;197(4300):263-5
   PubMed Web of Science ®Google Scholar
• Oram JD, Reiter B. Inhibition of bacteria by lactoferrin and other iron-chelating agents. Biochim Biophys Acta 1968;170(2):351-65
   PubMed Web of Science ®Google Scholar
• Flores-Villasenor H, Canizalez-Roman A, Reyes-Lopez M, Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli. Biometals 2010;23(3):569-78
   PubMed Web of Science ®Google Scholar
• Wakabayashi H, Abe S, Teraguchi S, Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds. Antimicrob Agents Chemother 1998;42(7):1587-91
   PubMed Web of Science ®Google Scholar
• Vorland LH, Ulvatne H, Andersen J, Antibacterial effects of lactoferricin B. Scand J Infect Dis 1999;31(2):179-84
   PubMed Web of Science ®Google Scholar
• Vorland LH. Lactoferrin: a multifunctional glycoprotein. APMIS 1999;107(11):971-81
   PubMed Web of Science ®Google Scholar
• Ellison RT III, Giehl TJ, LaForce FM. Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect Immun 1988;56(11):2774-81
   PubMed Web of Science ®Google Scholar
• Vorland LH, Ulvatne H, Rekdal O, Initial binding sites of antimicrobial peptides in Staphylococcus aureus and Escherichia coli. Scand J Infect Dis 1999;31(5):467-73
   PubMed Web of Science ®Google Scholar
• Gifford JL, Hunter HN, Vogel HJ. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell Mol Life Sci 2005;62(22):2588-98
   PubMed Web of Science ®Google Scholar
• Okuda M, Nakazawa T, Yamauchi K, Bovine lactoferrin is effective to suppress Helicobacter pylori colonization in the human stomach: a randomized, double-blind, placebo-controlled study. J Infect Chemother 2005;11(6):265-9
   PubMedGoogle Scholar
• Florisa R, Recio I, Berkhout B, Visser S. Antibacterial and antiviral effects of milk proteins and derivatives thereof. Curr Pharm Des 2003;9(16):1257-75
   PubMed Web of Science ®Google Scholar
• Seganti L, Di Biase AM, Marchetti M, Antiviral activity of lactoferrin towards naked viruses. Biometals 2004;17(3):295-9
   PubMed Web of Science ®Google Scholar
• Jenssen H. Anti herpes simplex virus activity of lactoferrin/lactoferricin – an example of antiviral activity of antimicrobial protein/peptide. Cell Mol Life Sci 2005;62(24):3002-13
   PubMed Web of Science ®Google Scholar
• Jenssen H, Andersen JH, Uhlin-Hansen L, Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate. Antiviral Res 2004;61(2):101-9
   PubMed Web of Science ®Google Scholar
• Ikeda M, Sugiyama K, Tanaka T, Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes. Biochem Biophys Res Commun 1998;245(2):549-53
   PubMed Web of Science ®Google Scholar
• Legrand D, Elass E, Pierce A, Mazurier J. Lactoferrin and host defence: an overview of its immuno-modulating and anti-inflammatory properties. Biometals 2004;17(3):225-9
   PubMed Web of Science ®Google Scholar
• Legrand D, Elass E, Carpentier M, Mazurier J. Interactions of lactoferrin with cells involved in immune function. Biochem Cell Biol 2006;84(3):282-90
   PubMed Web of Science ®Google Scholar
• Talukder MJ, Takeuchi T, Harada E. Characteristics of lactoferrin receptor in bovine intestine: higher binding activity to the epithelium overlying Peyer's patches. J Vet Med A Physiol Pathol Clin Med 2003;50(3):123-31
   PubMedGoogle Scholar
• Suzuki YA, Lopez V, Lonnerdal B. Mammalian lactoferrin receptors: structure and function. Cell Mol Life Sci 2005;62(22):2560-75
   PubMed Web of Science ®Google Scholar
• Takakura N, Wakabayashi H, Ishibashi H, Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model. J Med Microbiol 2004;53(Pt 6):495-500
   PubMed Web of Science ®Google Scholar
• Iigo M, Kuhara T, Ushida Y, Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin Exp Metastasis 1999;17(1):35-40
   PubMed Web of Science ®Google Scholar
• Roseanu A, Florian PE, Moisei M, Liposomalization of lactoferrin enhanced its anti-tumoral effects on melanoma cells. Biometals 2010;23(3):485-92
   PubMed Web of Science ®Google Scholar
• Yoo YC, Watanabe S, Watanabe R, Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice. Jpn J Cancer Res 1997;88(2):184-90
   PubMedGoogle Scholar
• Eliassen LT, Berge G, Sveinbjørnsson B, Evidence for a direct antitumor mechanism of action of bovine lactoferricin. Anticancer Res 2002;22(5):2703-10
   PubMed Web of Science ®Google Scholar
• Takakura N, Wakabayashi H, Yamauchi K, Takase M. Influences of orally administered lactoferrin on IFN-gamma and IL-10 production by intestinal intraepithelial lymphocytes and mesenteric lymph-node cells. Biochem Cell Biol 2006;84(3):363-8
   PubMed Web of Science ®Google Scholar
• Togawa J, Nagase H, Tanaka K, Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J Gastroenterol Hepatol 2002;17(12):1291-8
   PubMed Web of Science ®Google Scholar
• Hwang SA, Wilk KM, Bangale YA, Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes. Med Microbiol Immunol (Berl) 2007;196(3):171-80
   PubMed Web of Science ®Google Scholar
• Yamauchi K, Wakabayashi H, Shin K, Bovine lactoferrin: benefits and mechanism of action against infections. Biochem Cell Biol 2006;84(3):291-6
   PubMed Web of Science ®Google Scholar
• Mattsby-Baltzer I, Roseanu A, Motas C, Lactoferrin or a fragment thereof inhibits the endotoxin-induced interleukin-6 response in human monocytic cells. Pediatr Res 1996;40(2):257-62
   PubMed Web of Science ®Google Scholar
• Shimizu H. Development of an enteric-coated lactoferrin tablet and its application. Biometals 2004;17(3):343-7
   PubMed Web of Science ®Google Scholar
• Shoji H, Oguchi S, Shinohara K, Effects of iron-unsaturated human lactoferrin on hydrogen peroxide-induced oxidative damage in intestinal epithelial cells. Pediatr Res 2007;61(1):89-92
   PubMed Web of Science ®Google Scholar
• Britton JR, Koldovsky O. Luminal digestion of lactoferrin in suckling and weanling rats. Am J Physiol 1987;253(3 Pt 1):G397-403
   PubMed Web of Science ®Google Scholar
• Troost FJ, Saris WH, Brummer RJ. Orally ingested human lactoferrin is digested and secreted in the upper gastrointestinal tract in vivo in women with ileostomies. J Nutr 2002;132(9):2597-600
   PubMed Web of Science ®Google Scholar
• Nojima Y, Suzuki Y, Iguchi K, Development of poly(ethylene glycol) conjugated lactoferrin for oral administration. Bioconjug Chem 2008;19(11):2253-9
   PubMed Web of Science ®Google Scholar
• Kitagawa H, Yoshizawa Y, Yokoyama T, Persorption of bovine lactoferrin from the intestinal lumen into the systemic circulation via the portal vein and the mesenteric lymphatics in growing pigs. J Vet Med Sci 2003;65(5):567-72
   PubMed Web of Science ®Google Scholar
• Takeuchi T, Kitagawa H, Harada E, Evidence of lactoferrin transportation into blood circulation from intestine via lymphatic pathway in adult rats. Exp Physiol 2004;89(3):263-70
   PubMed Web of Science ®Google Scholar
• Drescher K, Roos N, Pfeuffer M, Recovery of 15N-lactoferrin is higher than that of 15N-casein in the small intestine of suckling, but not adult miniature pigs. J Nutr 1999;129(5):1026-30
   PubMed Web of Science ®Google Scholar
• Kuwata H, Yamauchi K, Teraguchi S, Functional fragments of ingested lactoferrin are resistant to proteolytic degradation in the gastrointestinal tract of adult rats. J Nutr 2001;131(8):2121-7
   PubMed Web of Science ®Google Scholar
• Troost FJ, Steijns J, Saris WH, Gastric digestion of bovine lactoferrin in vivo in adults. J Nutr 2001;131(8):2101-4
   PubMed Web of Science ®Google Scholar
• Takeuchi T, Jyonotsuka T, Kamemori N, Enteric-formulated lactoferrin was more effectively transported into blood circulation from gastrointestinal tract in adult rats. Exp Physiol 2006;91(6):1033-40
   PubMed Web of Science ®Google Scholar
• Wakabayashi H, Abe S, Teraguchi S, Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds. Antimicrob Agents Chemother 1998;42(7):1587-91
   PubMed Web of Science ®Google Scholar
• Samaranayake YH, Samaranayake LP, Pow EH, Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort. J Clin Microbiol 2001;39(9):3296-302
   PubMed Web of Science ®Google Scholar
• Kuipers ME, Heegsma J, Bakker HI, Design and fungicidal activity of mucoadhesive lactoferrin tablets for the treatment of oropharyngeal candidosis. Drug Deliv 2002;9(1):31-8
   PubMed Web of Science ®Google Scholar
• Kaneda Y, Tsutsumi Y, Yoshioka Y, The use of PVP as a polymeric carrier to improve the plasma half-life of drugs. Biomaterials 2004;25(16):3259-66
   PubMed Web of Science ®Google Scholar
• Veronese FM, Morpurgo M. Bioconjugation in pharmaceutical chemistry. Farmaco 1999;54(8):497-516
   PubMedGoogle Scholar
• Kaneda Y, Tsutsumi Y, Yoshioka Y, The use of PVP as a polymeric carrier to improve the plasma half-life of drugs. Biomaterials 2004;25(16):3259-66
   PubMed Web of Science ®Google Scholar
• Zhang YQ, Zhou WL, Shen WD, Synthesis, characterization and immunogenicity of silk fibroin-L-asparaginase bioconjugates. J Biotechnol 2005;120(3):315-26
   PubMed Web of Science ®Google Scholar
• Zhang YQ, Ma Y, Xia YY, Silk sericin-insulin bioconjugates: synthesis, characterization and biological activity. J Control Release 2006;115(3):307-15
   PubMed Web of Science ®Google Scholar
• Veronese FM, Pasut G. PEGylation, successful approach to drug delivery. Drug Discov Today 2005;10(21):1451-8
   PubMed Web of Science ®Google Scholar
• Bailon P, Won CY. PEG-modified biopharmaceuticals. Expert Opin Drug Deliv 2009;6(1):1-16
   PubMed Web of Science ®Google Scholar
• Foster GR. Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus. Expert Opin Pharmacother 2003;4(5):685-91
   PubMed Web of Science ®Google Scholar
• Davis FF. PEG-adenosine deaminase and PEG-asparaginase. Adv Exp Med Biol 2003;519:51-8
   PubMed Web of Science ®Google Scholar
• Park YK, Abuchowski A, Davis S, Davis F. Pharmacology of Escherichia coli-L-asparaginase polyethylene glycol adduct. Anticancer Res 1981;1(6):373-6
   PubMed Web of Science ®Google Scholar
• Nojima Y, Suzuki Y, Yoshida K, Lactoferrin conjugated with 40-kDa branched poly(ethylene glycol) has an improved circulating half-life. Pharm Res 2009;26(9):2125-32
   PubMed Web of Science ®Google Scholar
• Sugiyama A, Sato A, Takeuchi T. PEGylated lactoferrin enhanced its hepatoprotective effects on acute liver injury induced by carbon tetrachloride in rats. Food Chem Toxicol 2009;47(7):1453-8
   PubMed Web of Science ®Google Scholar
• Wong CK, Ooi VE, Ang PO. Protective effects of seaweeds against liver injury caused by carbon tetrachloride in rats. Chemosphere 2000;41(1-2):173-6
   PubMed Web of Science ®Google Scholar
• Saffran M, Kumar GS, Savariar C, A new approach to the oral administration of insulin and other peptide drugs. Science 1986;233(4768):1081-4
   PubMed Web of Science ®Google Scholar
• Reddy SM, Sinha VR, Reddy DS. Novel oral colon-specific drug delivery systems for pharmacotherapy of peptide and nonpeptide drugs. Drugs Today (Barc) 1999;35(7):537-80
   PubMed Web of Science ®Google Scholar
• Ogue S, Takahashi Y, Onishi H, Machida Y. Preparation of double liposomes and their efficiency as an oral vaccine carrier. Biol Pharm Bull 2006;29(6):1223-8
   PubMed Web of Science ®Google Scholar
• Guillen C, McInnes IB, Vaughan D, The effects of local administration of lactoferrin on inflammation in murine autoimmune and infectious arthritis. Arthritis Rheum 2000;43(9):2073-80
   PubMed Web of Science ®Google Scholar
• Ziere GJ, van Dijk MC, Bijsterbosch MK, Lactoferrin uptake by the rat liver. Characterization of the recognition site and effect of selective modification of arginine residues. J Biol Chem 1992;267(16):11229-35
   PubMed Web of Science ®Google Scholar
• Trif M, Guillen C, Vaughan DM, Liposomes as possible carriers for lactoferrin in the local treatment of inflammatory diseases. Exp Biol Med 2001;226(6):559-64
   PubMed Web of Science ®Google Scholar
• Ishikado A, Imanaka H, Takeuchi T, Liposomalization of lactoferrin enhanced it's anti-inflammatory effects via oral administration. Biol Pharm Bull 2005;28(9):1717-21
   PubMed Web of Science ®Google Scholar
• Zemann N, Klein P, Wetzel E, Lactoferrin induces growth arrest and nuclear accumulation of Smad-2 in HeLa cells. Biochimie 2010;92(7):880-4
   PubMed Web of Science ®Google Scholar
• Onishi H, Machida Y, Koyama K. Preparation and in vitro characteristics of lactoferrin-loaded chitosan microparticles. Drug Dev Ind Pharm 2007;33(6):641-7
   PubMed Web of Science ®Google Scholar
• Koyama K, Onishi H, Sakata O, Machida Y. Preparation and in vitro evaluation of chitosan-coated alginate/calcium complex microparticles loaded with fluorescein-labeled lactoferrin. Yakugaku Zasshi 2009;129(12):1507-14
   PubMed Web of Science ®Google Scholar
• Zimecki M, Miedzybrodzki R, Szymaniec S. Oral treatment of rats with bovine lactoferrin inhibits carrageenan-induced inflammation; correlation with decreased cytokine production. Arch Immunol Ther Exp (Warsz) 1998;46(6):361-5
   PubMedGoogle Scholar
• Onishi H, Koyama K, Sakata O, Machida Y. Preparation of chitosan/alginate/calcium complex microparticles loaded with lactoferrin and their efficacy on carrageenan-induced edema in rats. Drug Dev Ind Pharm 2010;36(8):879-84
   PubMed Web of Science ®Google Scholar